PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.\', \'Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, Valencia, 46001, Spain.\', \'School of Pharmacy & Pharmaceutical Sciences, Ulster University, Londonderry, Northern Ireland, UK.\', \'Department of Physiology, Michigan State University, East Lansing, Michigan, 48824, USA.\', \'University of Pittsburgh, Magee-Women\'s Hospital, Pittsburgh, Pennsylvania, 15213, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/sctm.21-0183
?:hasPublicationType
?:journal
  • Stem cells translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34302450
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.722
?:rankingScore_hIndex
  • 45
?:title
  • SARS-CoV-2 research using human pluripotent stem cells and organoids.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34302450>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34302450>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all